Tungtex (Holdings) Company Limited
TUGHF News Today: Stay Updated with the Latest Tungtex (Holdings) Company Limited News in Real Time
Find TUGHF news now at Meyka AI. Stay informed with the latest Tungtex (Holdings) Company Limited stocks updates, including price news, market analysis, and expert insights.
BKW.AX Brickworks ASX A$33.02 pre-market 17/03/2026: oversold bounce to A$35.50
BKW.AX stock down to A$33.02 pre-market 17/03/2026; oversold bounce scenario and price targets from A$35.50 to A$42.10
William Blair, Leerink Maintain Outperform on Structure Therapeutics (GPCR) Mar 2026
Two firms maintain Outperform on Structure Therapeutics; GPCR analyst rating stays positive after March 16, 2026 updates
PEL.NS Piramal Enterprises (NSE) pre-market 17 Mar 2026: oversold bounce watch
PEL.NS stock pre-market update 17 Mar 2026—oversold bounce set-up, key targets and Meyka AI forecast
Volume spike at Aerkomm Inc (AKOM.PA) EURONEXT 16 Mar 2026: watch liquidity
AKOM.PA stock jumps on volume spike to EUR 2.80; our volume-driven analysis and forecast for EURONEXT traders
SANN.SW -5.83% to CHF14.54 on 16 Mar 2026: model flags 13.42% upside
SANN.SW stock fell 5.83% to CHF14.54 on SIX; Meyka forecast CHF16.49 (13.42% upside)
Earnings pre-market 17 Mar 2026: CAICA DIGITAL (2315.T JPX) key metrics to watch
Pre-market earnings spotlight on 2315.T stock: CAICA DIGITAL reports 17 Mar 2026. Key metrics, valuation and Meyka AI forecast
HK$276.80 pre-market Unisound 9678.HK (HKSE) 17 Mar 2026: AI outlook
Pre-market analysis of 9678.HK stock Unisound at HK$276.80, technicals, Meyka AI grade and forecast
Almonty Industries (ALI1.DE XETRA) at €16.60 ahead of 19 Mar earnings: will Sangdong output sustain gains
Earnings spotlight on ALI1.DE stock: **€16.60** price, 19 Mar results, Meyka AI forecast and short-term price scenarios
Japan MHLW March 17: 2026 Fee Overhaul Prioritizes Drug Supply Stability
Japan MHLW 2026 medical fee overhaul shifts rewards to drug supply stability and leftover‑medicine cuts, raises co-pays on long-listed drugs, and changes pharmacy incentives that could reshape margins